Insights

A&M Newsletters
Comprehensive and timely perspectives, on the topics that matter to you, sent straight to your inbox.
Created
Thought Leadership

Key Tax Ruling on Outbound Software Payments: Business Profits vs. Royalties

September 11, 2025
Thailand's latest tax ruling on outbound software payments introduces a rights-based approach to classify payments as business profits or royalties. This shift aligns with international tax standards and impacts cross-border technology transactions, including cloud computing and custom software development. Learn how to optimize withholding tax exposure under this new interpretation.
Thought Leadership

Beyond Stay or Leave: How MNCs Are Recalibrating Their China Strategy

September 11, 2025
The old playbook for multinational companies (MNCs) in China no longer works. Five years ago, MNCs could translate superior technology, products, and management models into easy profits in the world’s second-largest economy. Today, the competitive landscape has shifted.
Thought Leadership

Changes Coming to the Washington Sales Tax Landscape on October 1, 2025

September 11, 2025
In May 2025, Washington enacted multiple tax bills into law, including Senate Bill 5814 (SB 5814), which takes effect on October 1st and will broaden the sales and use tax base and the Business and Occupation (B&O) tax retailing classification to include several new services.

Griffin Coal

September 10, 2025
Griffin Coal - A&M AUS Insolvency Portal

Entyr Group

September 10, 2025
Entyr Group - A&M AUS Insolvency Portal
Thought Leadership

Private Equity Value Creation Report: Australia 2025

September 10, 2025
The Australian private equity market is set to play a pivotal role in shaping the country’s economic future. In our inaugural Australia Private Equity Value Creation report, we deep dive into how Australian-focused PE funds and operators are performing and how their strategies compare globally.
Thought Leadership

SWISS DEBT RESTRUCTURING MORATORIUM SURVEY 2024

September 9, 2025
Alvarez & Marsal's new Swiss Debt Restructuring Moratorium Survey reveals the number of cases peaked once again in 2024, building on the increased utilization already observed in 2023.
Thought Leadership

What if the biosimilar wave is just a ripple?

September 9, 2025
As biologics face a record-breaking patent cliff, the anticipated biosimilar wave may be more of a ripple than a wave. To thrive, life sciences firms must shift from solely pursuing speed to mastering precision.